Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China
Crossref DOI link: https://doi.org/10.1186/s12885-015-1534-0
Published Online: 2015-07-29
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Zengjun
Li, Fei
Yi, Shuhua
Gu, Zhimin
Yu, Zhen
Xu, Yan
Feng, Xiaoyan
Liu, Wei
Zou, Dehui
Qi, Junyuan
Zhan, Fenghuang
Qiu, Lugui
License valid from 2015-07-29
Article History
Received: 10 February 2015
Accepted: 7 July 2015
First Online: 29 July 2015